Glomerulonephritis, IGA: Clinical Trials

1 trial for Glomerulonephritis, IGA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Glomerulonephritis, IGA: new trials by email Literature Review of Glomerulonephritis, IGA trials Research Report on Glomerulonephritis, IGA

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Aliskiren, Valsartan - Proteinuric Kidney Disease, Diabetic Nephropathy
Phase 4TerminatedColumbia University462009-09-012014-05-15

Narrower conditions

Diabetic Nephropathies (1)  ·  Glomerulonephritis, Membranous (1)  ·  Glomerulosclerosis, Focal Segmental (1)

Broader conditions

Autoimmune Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Valsartan (1)  ·  aliskiren (1)

Sponsors

Columbia University (1)

Countries

United States (1)

Top investigators

Pietro Canetta, MD (1)

Results publications

PMID 22995802